Evolus back on track with Botox rival that was sidelined by manufacturing CRL
admin 29th August 2018 Uncategorised 0Evolus, which had its Botox rival sidelined by the FDA in May over CMC concerns, believes it has its manufacturing figured out and says it is back on track with an action date.
More: Evolus back on track with Botox rival that was sidelined by manufacturing CRL
Source: fierce